Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
The American Journal of Pathology
|
December 24, 1997
MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution
G F Hofbauer, C Schaefer, C Noppen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
R Strohal, B Kirby, L Puig, et al.
Clinical Immunology (Orlando, Fla.)
|
March 3, 2009
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy
U Laggner, J S Lopez, G Perera, et al.
The British Journal of Dermatology
|
May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial
K Reich, F O Nestle, K Papp, et al.
Clinical and Experimental Immunology
|
July 22, 2018
Skin resident memory CD8<sup>+</sup> T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function
J A Seidel, M Vukmanovic-Stejic, B Muller-Durovic, et al.
The Journal of Dermatological Treatment
|
February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper
G Girolomoni, C E M Griffiths, J Krueger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 17, 2011
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity
S M Rudman, D H Josephs, H Cambrook, et al.
Allergy
|
April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
D H Josephs, M Nakamura, H J Bax, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
The American Journal of Pathology
|
December 24, 1997
MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution
G F Hofbauer, C Schaefer, C Noppen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
R Strohal, B Kirby, L Puig, et al.
Clinical Immunology (Orlando, Fla.)
|
March 3, 2009
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy
U Laggner, J S Lopez, G Perera, et al.
The British Journal of Dermatology
|
May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial
K Reich, F O Nestle, K Papp, et al.
Clinical and Experimental Immunology
|
July 22, 2018
Skin resident memory CD8<sup>+</sup> T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function
J A Seidel, M Vukmanovic-Stejic, B Muller-Durovic, et al.
The Journal of Dermatological Treatment
|
February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper
G Girolomoni, C E M Griffiths, J Krueger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 17, 2011
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity
S M Rudman, D H Josephs, H Cambrook, et al.
Allergy
|
April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
D H Josephs, M Nakamura, H J Bax, et al.
Page
of 7